Venture Capitalist Palihapitiya’s 4 DNA SPACs = More Proof of My Thesis
Venture capitalist Chamath Palihapitiya recently announced plans for four DNA SPACs, and that’s a huge deal for genomics stocks going forward.
Read More
Author: Adam O'Dell
Super Salmon: One Key to Fish Farm Disruption
One company’s “Super Salmon” model is ready to revolutionize the fish farming process, putting more money in the pockets of its investors.
Fish-Farming Industry Is Ripe for Disruption
Genomics is not limited to DNA-medicine. It’s also a tech disruptor in other industries like fish farming, and that offers some profitable opportunities.
Aging Boomers: A Perfect Tailwind for Genomics Stocks
Aging baby boomers are a decades-long tailwind for genomics stocks as scientists develop DNA-based medicine to fight prolific diseases.
Biotech Barbell: The Best Way to Invest in a “Risky” Sector
Investing in a segment like biotech doesn’t have to feel risky. The “barbell” strategy creates a balance between high- and low-risk assets.
Watchlist
